Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00321126Phase 3Completed
Phase 3, randomised, double-blind trial in shigellosis comparing Zinc Group with Placebo Group (2 arms). Primary endpoints: Duration of diarrhoea before admission, Stool volume and 3 more. Started Jan 1999; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00321126.